Main menu For students For teachers Explore our subjects Student events & courses

Teaching Economics

In the News

Nurofen fined heavily for mis-leading consumers

Graham Watson

16th December 2016

Share this content:

Another instance of the regulator intervening to protect consumers from exploitation by another pharmaceutical company. In this instance, the manufacturer of Nurofen, Reckitt Benckiser, has seen its fine increase from $1.7m to $6m, for misleading branding of identical products.

My take on this? Don't buy Nurofen in the first place - generic ibuprofen is identical. However, that said, some studies suggest that pricier painkillers are 'better' at providing pain relief - if only because of their psychosomatic effects.

Share this content:

Graham Watson

Graham Watson has taught Economics for over twenty years. He contributes to Tutor2U, reads voraciously and is interested in all aspects of Teaching and Learning.